๐ฐ Continued Examination News
Page 3 - Continued Examination News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Continued Examination. Real-time updates on events, politics, business and more.
October 1, 2022
Earlier this month, the Federal Circuit affirmed the grant of summary judgment in favor of the U.S. Patent and Trademark Office by the U.S. District Court for the Eastern District of...
September 7, 2022
USPTO Launches Webpage on PTE Applications and Patent Terms Extended under 35 U.S.C. § 156 - In a Patent Alert email distributed to stakeholders last week, the U.S....
August 4, 2022
The Canadian government has now announced that October 3, 2022, is the date on which significant changes to the Canadian Patent Rules, which we had previously reported, will come into...
August 4, 2022
The Canadian government has now announced that October 3, 2022, is the date on which significant changes to the Canadian Patent Rules, which we had previously reported, will come into...
August 4, 2022
The Canadian government has now announced that October 3, 2022, is the date on which significant changes to the Canadian Patent Rules, which we had previously reported, will come into force.
July 20, 2022
The USPTO Patent Term Adjustment (PTA) rules include a "safe harbor" that avoids a PTA deduction for "Applicant delay" for Information Disclosure Statements that are accompanied by a certain statement...
July 15, 2022
He United States Patent & Trademark Office (USPTO) is proposing to amend 37 C.F.R. § 1.704(d) to require that the patent term adjustment statement regarding the timing ...
June 10, 2022
Rules amending the Patent Rules1 were registered on June 2, 2022 and will largely come into force on October 3, 2022. The rules introduce claim fees and a continued examination scheme...
March 21, 2022
In recent years the United States Patent and Trademark Office has taken strides to reduce on average the duration of time between the filing of a patent application and either abandonment or issuance.
March 8, 2022
Patent protection, regulatory exclusivity and product life cycle management should be at the core of any companyโs life science development strategy. A well-integrated strategy will be...